Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

NAVB

Navidea Biopharmaceuticals (NAVB)

Navidea Biopharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:NAVB
FechaHoraFuenteTítuloSímboloCompañía
21/12/202314:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
05/12/202317:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
01/12/202310:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
23/10/202312:56Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
05/10/202320:01Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockAMEX:NAVBNavidea Biopharmaceuticals Inc
05/10/202315:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
15/09/202314:42Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
10/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NAVBNavidea Biopharmaceuticals Inc
15/08/202316:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
11/08/202315:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NAVBNavidea Biopharmaceuticals Inc
10/08/202308:29Business WireNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAMEX:NAVBNavidea Biopharmaceuticals Inc
31/07/202308:32Business WireNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
28/07/202319:23Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationAMEX:NAVBNavidea Biopharmaceuticals Inc
27/07/202316:20Business WireNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerAMEX:NAVBNavidea Biopharmaceuticals Inc
13/07/202316:09Business WireNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownAMEX:NAVBNavidea Biopharmaceuticals Inc
03/07/202315:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
30/06/202309:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:NAVBNavidea Biopharmaceuticals Inc
30/06/202308:16Business WireNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsAMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202316:23Edgar (US Regulatory)Current Report Filing (8-k)AMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202316:00Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)AMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202315:54Business WireNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common StockAMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202312:52Business WireNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentAMEX:NAVBNavidea Biopharmaceuticals Inc
07/06/202315:00Business WireNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateAMEX:NAVBNavidea Biopharmaceuticals Inc
02/06/202316:54Business WireNavidea Biopharmaceuticals, Inc. Receives NYSE American NoticeAMEX:NAVBNavidea Biopharmaceuticals Inc
01/06/202316:53Business WireNavidea Biopharmaceuticals, Inc. Welcomes Jill Bieker Stefanelli, Ph.D. to Board of Directors; Alexander L. Cappello Steps DownAMEX:NAVBNavidea Biopharmaceuticals Inc
01/06/202305:03Edgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:NAVBNavidea Biopharmaceuticals Inc
22/05/202317:30Business WireNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at MarketAMEX:NAVBNavidea Biopharmaceuticals Inc
11/05/202316:35Business WireNavidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical OfficerAMEX:NAVBNavidea Biopharmaceuticals Inc
11/05/202315:57Edgar (US Regulatory)Quarterly Report (10-q)AMEX:NAVBNavidea Biopharmaceuticals Inc
08/05/202315:12Business WireNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for CommunicationsAMEX:NAVBNavidea Biopharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:NAVB

Su Consulta Reciente

Delayed Upgrade Clock